Since starting the ACR on Air podcast in 2019, Mohammad Ursani, MD, FACP, RhMSUS, has become chair of the Committee on Communications and Marketing. Here, he shares some plans for the ACR website, podcast and more.... [Read More]
Kelly Tyrrell writes about health, science and health policy. Based in Madison, Wis., she has a BS in zoology from the University of Florida and an MS in cellular and molecular biology from the University of Wisconsin–Madison. In 2011, she was a mass media dcience and engineering fellow with the American Association for the Advancement of Science (AAAS), reporting for the Chicago Tribune. Ms. Tyrrell has also worked as a health and science reporter for the News Journal (Gannett) in Wilmington, DE, a freelance reporter for the Philadelphia Inquirer and a science writer for UW-Madison.
Articles by Kelly Tyrrell
Experts Share Insights & Advice on Reproductive Health for Patients with Rheumatic Disease
Contraception, disease control, family planning and managing life with an infant—five experts addressed these concerns and more for patients with rheumatic disease during a special online webinar.... [Read More]
New Editor Looks to Strengthen AC&R’s Connections to Clinical Care
Kelli Allen, PhD, believes strongly in the mission of AC&R, and as the journal’s new editor in chief, it’s now in her hands to carry that mission forward. Dr. Allen assumed the role on July 1, following the decade-long tenure of Dr. Hannan. “Everyone has been very generous with their time and the managing editors… [Read More]
Timothy Laing, MD, Reappointed to AMA’s Relative Value System Update Committee
Timothy Laing, MD, will continue to represent the ACR in his third stint on the AMA’s Relative Value System Update Committee, helping determine the relative value of clinical services.... [Read More]
5 Challenges in the Treatment & Diagnosis of Lupus
A recent study published in Lupus Science & Medicine lays out five of the top barriers impeding progress in lupus diagnosis and treatment.1 The Addressing Lupus Pillars for Health Advancement project (ALPHA), led by the Lupus Foundation of America (LFA), researchers at the Tufts School of Medicine Center for the Study of Drug Development (Tufts… [Read More]
Meet the Incoming Arthritis & Rheumatology Editor in Chief, Dr. Daniel Solomon
Daniel Solomon, MD, MPH, has practiced rheumatology for more than 20 years, all while conducting translational and clinical research and teaching young clinicians. Soon, he will also step into the role of editor in chief of Arthritis & Rheumatology, as Richard J. Bucala, MD, PhD, ends his tenure. He will assume some duties during a… [Read More]
Sindhu Johnson, MD, PhD, FRCPC, to Head the Committee on Quality of Care
Sindhu Johnson, MD, PhD, FRCPC, has co-chaired the classification and response criteria subcommittee and brings extensive experience in classification and guideline development to her new role.... [Read More]
Rheumatology Patients & Providers Push for Step Therapy, Workforce Changes
Rheumatology professional and patients visited with 117 legislators and their staffs during the 2019 Advocates for Arthritis event to champion better rheumatology patient care and access.... [Read More]
Get Members Involved: That’s How Nevada Is Growing Its State Society
In April 2019, the Rheumatology Association of Nevada (RAN) hosted its fourth annual meeting. “We had the largest-ever number of attendees,” says RAN President Tim Kelly, MD, a rheumatologist in Las Vegas. Launched in 2016, RAN continues to grow, and Dr. Kelly hopes to see the statewide organization do more. “We want to expand our… [Read More]
CMS Rule Reflects ACR’s Advocacy, but More Patient Protections Needed
In August 2018, the Centers for Medicare and Medicaid Services (CMS) announced it would permit Medicare Advantage plans to use step therapy for Part B drugs, with a lookback period of just 108 days.1 On May 16, 2019, however, the CMS issued a final rule that extends the lookback period for Part B therapies to 365… [Read More]
- 1
- 2
- 3
- …
- 7
- Next Page »